How to Start a Biotech Venture
Technische Universität München (Technical University of Munich) via Coursera
-
85
-
- Write review
Overview
Google, IBM & Meta Certificates – 40% Off
One Coursera Plus subscription covers most Professional Certificates on Coursera.
Unlock All Certificates
Biotech companies are transforming the world, but launching a biotech startup comes with unique challenges—protecting intellectual property, securing funding, and building a strong team.
This course empowers you with the knowledge and confidence to tackle these issues. You’ll learn how to build a high-performing team, manage finances effectively, ensure your venture is aligned with the market, protect your intellectual property, and navigate legal and regulatory hurdles.
Offered by the Technical University of Munich, one of Europe’s leading research and innovation hubs, the course combines academic expertise with practical insights from industry experts, patent attorneys, and entrepreneurs who share their real-world advice and experiences, giving you the tools to successfully bring your biotech innovation to life.
Syllabus
- Course Welcome
- Building Your Team
- This module covered how to build a strong founding team, shape company culture, attract investors, hire early employees, and involve external advisors from the start.
- Understanding Finance & Accounting
- Defining Your Market Strategy
- Protecting Your Intellectual Property
- Navigating the Legal Landscape
- Summary & Goodbye
Taught by
Dr. Svenja Jarchow
Tags
Reviews
5.0 rating, based on 1 Class Central review
Showing Class Central Sort
-
Biotech ventures are honestly one of the best things to dive into especially if you care about solving real problems like Cancer, HIV/AIDS, and other big challenges humanity faces. It’s a space where science meets ambition, and the payoff isn’t just money but saving lives. I think it’s a smart move to lean in with capital-intensive resources like advanced technology, because that’s how you get real breakthroughs. This course gave me a solid perspective on how biotech works from the inside. It didn’t shy away from the tough realities but also showed the opportunities